Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations.
about
Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment.KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex.Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.Pancreatic cancer subtypes: a roadmap for precision medicine
P2860
Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Pancreatic cancer: Circulating ...... Heterogeneous KRAS Mutations.
@en
type
label
Pancreatic cancer: Circulating ...... Heterogeneous KRAS Mutations.
@en
prefLabel
Pancreatic cancer: Circulating ...... Heterogeneous KRAS Mutations.
@en
P2093
P2860
P1433
P1476
Pancreatic cancer: Circulating ...... w Heterogeneous KRAS Mutations
@en
P2093
Gabriel Seifert
Heiko Becker
Jasmina Kuvendjiska
Jens Hoeppner
Martha B Pitman
Peter Bronsert
Saskia Hussung
Sindy Seifert
Stephanie Rösch
Sylvia Timme
P2860
P2888
P356
10.1038/S41598-017-04601-Z
P407
P577
2017-07-03T00:00:00Z